Panacea Biotec Receives Amended Award from UNICEF for Supply of Pentavalent Vaccine, Easyfive-TT - Increase in Value by US$ 8.93 Million for CY2026 and CY2027

Panacea Biotec Ltd. has received an amended Award from UNICEF for the supply of its WHO pre-qualified fully liquid Pentavalent vaccine, Easyfive-TT® (DTwP-HepB-Hib) for supplies during calendar years 2023-2027. The amendment includes an increase in value by US$ 2.55 million (~Rs.23 Crore) for CY2026, US$ 2.70 million (~Rs.24 Crore) for CY2027, and an additional Award for supply of Easyfive-TT® worth ~US$ 3.68 million (~Rs.33 Crore) in CY2027. The total increase in value is US$ 8.93 million (~Rs.80 Crore).